Lumos Pharma, Inc.
LUMO · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,467 | -$7,551 | -$10,441 | -$9,457 |
| Dep. & Amort. | -$1 | $2 | $2 | $18 |
| Deferred Tax | $0 | $0 | $0 | $159 |
| Stock-Based Comp. | $379 | $387 | $580 | $524 |
| Change in WC | $2,252 | $782 | -$3,034 | $1,552 |
| Other Non-Cash | -$169 | -$131 | $3,180 | -$189 |
| Operating Cash Flow | -$5,006 | -$6,380 | -$12,894 | -$7,393 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$13,205 |
| Net Acquisitions | $0 | $0 | $0 | $7,033 |
| Inv. Purchases | $0 | $0 | $0 | -$998 |
| Inv. Sales/Matur. | $0 | $0 | $1,000 | $7,170 |
| Other Inv. Act. | -$1,000 | $0 | $1,000 | $6,172 |
| Investing Cash Flow | $0 | $0 | $1,000 | $6,172 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $11 | $0 | $742 |
| Stock Repurch. | $16 | -$11 | -$5 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4 | -$11 | -$5 | $17 |
| Financing Cash Flow | $1,726 | $0 | -$5 | $742 |
| Forex Effect | $0 | $0 | $0 | $8,750 |
| Net Chg. in Cash | -$3,280 | -$6,380 | -$11,899 | -$479 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16,799 | $23,179 | $35,078 | $35,557 |
| End Cash | $13,519 | $16,799 | $23,179 | $35,078 |
| Free Cash Flow | -$5,006 | -$6,380 | -$12,894 | -$20,598 |